NeoSpect (depreotide)
- Region
- 🇪🇺 EU
- Active substance
- depreotide
- Company
- CIS bio international
- Status
- Withdrawn
- Therapeutic area
- Radionuclide Imaging
- EU approval
- Wed 29 Nov 2000
- Application
- EMEA/H/C/000263
- ATC
- V09IA05
- Official record
- www.ema.europa.eu
Indication
This medicinal product is for diagnostic use only.For scintigraphic imaging of suspected malignant tumours in the lung after initial detection, incombination with CT scan or chest X-ray, in patients with solitary pulmonary nodules.
Regulatory milestones
No milestones recorded in the last year.
Follow NeoSpect
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.